Publications by authors named "Ismail Haroon Mitha"

Claim this Profile
E
Eptacog beta efficacy and safety in the treatment and control of bleeding in paediatric subjects (<12 years) with haemophilia A or B with inhibitors.
Steven W Pipe, Cédric Hermans, Meera Chitlur, Manuel Carcao, Giancarlo Castaman, Ismail Haroon Mitha

Haemophilia· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A.
Robert Klamroth, Gregory Hayes, Tatiana Andreeva, Keith Gregg, Takashi Suzuki, Ismail Haroon Mitha

Hum Gene Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
Miguel Escobar, James Luck, Yevhenii Averianov, Jonathan Ducore, Maria Fernanda López Fernández, Ismail Haroon Mitha

Haemophilia· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The safety of activated eptacog beta in the management of bleeding episodes and perioperative haemostasis in adult and paediatric haemophilia patients with inhibitors.
Miguel Escobar, Giancarlo Castaman, Santiago Bonanad Boix, Michael Callaghan, Philippe de Moerloose, Ismail Haroon Mitha

Haemophilia· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics, Safety and Efficacy of Maraviroc in Treatment-experienced Pediatric Patients Infected With CCR5-Tropic HIV-1.
Carlo Giaquinto, Muthuhadini Patience Mawela, Kulkanya Chokephaibulkit, Marinella Della Negra, Ismail Haroon Mitha

Pediatr Infect Dis J· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis